CONGRESS | #ASCO21 | Faith Davies, NYU Langone Health, kicks off the session on high-risk MM! We are moving forward to a consensus in defining HR #myeloma. R-ISS needs to incorporate 1q+ and clinical features, which could weigh more than genetics in older patients #mmsm

CONGRESS | #ASCO21 | How to treat high-risk NDMM? Several studies are exploring if BCMA-directed therapy will improve, at last, the prognosis of these patients. Until then, see below Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 recommendations on the current treatment strategies 👇 #mmsm Levine Cancer